Jan Skoda

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Early Breast Cancer

Endoplasmic Reticulum Stress

Cancer Stem Cells

Signaling Pathway

Top Venues

Cellular & molecular biology letters

International journal of molecular sciences

The EMBO journal

This page only lists publications with an associated author ORCID identifier.

Publications

Petr Pleskač, Christine A Fargeas, Renata Veselska, Denis Corbeil, Jan Skoda
Emerging roles of prominin-1 (CD133) in the dynamics of plasma membrane architecture and cell signaling pathways in health and disease. Cellular & molecular biology letters 29 (1) (2024)
Petr Pleskač, Christine A Fargeas, Renata Veselska, Denis Corbeil, Jan Skoda
Emerging roles of prominin-1 (CD133) in the dynamics of plasma membrane architecture and cell signaling pathways in health and disease. Cellular & molecular biology letters 29 (1) (2024)
Petr Pleskač, Christine A Fargeas, Renata Veselska, Denis Corbeil, Jan Skoda
Emerging roles of prominin-1 (CD133) in the dynamics of plasma membrane architecture and cell signaling pathways in health and disease. Cellular & molecular biology letters 29 (1) (2024)
Karolina Borankova, Maria Krchniakova, Lionel Y W Leck, Adela Kubistova, Jakub Neradil, Patric Jan Jansson, Michael D Hogarty, Jan Skoda
Mitoribosomal synthetic lethality overcomes multidrug resistance in MYC-driven neuroblastoma. Cell death & disease 14 (11) (2023)
Joana Filipa D Almeida, Inês Mota, Jan Skoda, Maria Emília Sousa, Honorina Cidade, Lucília Saraiva
Deciphering the Role of p53 and TAp73 in Neuroblastoma: From Pathogenesis to Treatment. Cancers 14 (24) (2022)
Joana Filipa D Almeida, Inês Mota, Jan Skoda, Maria Emília Sousa, Honorina Cidade, Lucília Saraiva
Deciphering the Role of p53 and TAp73 in Neuroblastoma: From Pathogenesis to Treatment. Cancers 14 (24) (2022)
Polina Kameneva, Victoria I Melnikova, Maria Eleni Kastriti, Anastasia I Kurtova, Emil Kryukov, Aliia Murtazina, Louis Faure, Irina Poverennaya, Artem V Artemov, Tatiana S Kalinina, Nikita V Kudryashov, Michael Bader, Jan Skoda, Petr Chlapek, Lucie Curylova, Lukas Sourada, Jakub Neradil, Markéta Tesařová, Massimo Pasqualetti, Patricia Gaspar, Vasily D Yakushov, Boris I Sheftel, Tomas Zikmund, Josef Kaiser, Kaj Fried, Natalia Alenina, Elena E Voronezhskaya, Igor Adameyko
Serotonin limits generation of chromaffin cells during adrenal organ development. Nature communications 13 (1) (2022)
Silvia Paukovcekova, Maria Krchniakova, Petr Chlapek, Jakub Neradil, Jan Skoda, Renata Veselska
Thiosemicarbazones Can Act Synergistically with Anthracyclines to Downregulate CHEK1 Expression and Induce DNA Damage in Cell Lines Derived from Pediatric Solid Tumors. International journal of molecular sciences 23 (15) (2022)
Jorida Çoku, David M Booth, Jan Skoda, Madison C Pedrotty, Jennifer Vogel, Kangning Liu, Annette Vu, Erica L Carpenter, Jamie C Ye, Michelle A Chen, Peter Dunbar, Elizabeth Scadden, Taekyung D Yun, Eiko Nakamaru-Ogiso, Estela Area-Gomez, Yimei Li, Kelly C Goldsmith, C Patrick Reynolds, György Hajnóczky, Michael D Hogarty
Reduced ER-mitochondria connectivity promotes neuroblastoma multidrug resistance. The EMBO journal 41 (8) (2022)
Peter Macsek, Jan Skoda, Maria Krchniakova, Jakub Neradil, Renata Veselska
Iron-Chelation Treatment by Novel Thiosemicarbazone Targets Major Signaling Pathways in Neuroblastoma. International journal of molecular sciences 23 (1) (2021)
Nicole A Seebacher, Maria Krchniakova, Alexandra E Stacy, Jan Skoda, Patric Jan Jansson
Tumour Microenvironment Stress Promotes the Development of Drug Resistance. Antioxidants (Basel, Switzerland) 10 (11) (2021)
Jan Skoda, Jakub Neradil, Iva Zambo, Alena Nunukova, Peter Macsek, Karolina Borankova, Viera Dobrotkova, Pavel Nemec, Jaroslav Sterba, Renata Veselska
Serial Xenotransplantation in NSG Mice Promotes a Hybrid Epithelial/Mesenchymal Gene Expression Signature and Stemness in Rhabdomyosarcoma Cells. Cancers 12 (1) (2020)
Silvia Paukovcekova, Jan Skoda, Jakub Neradil, Erika Mikulenkova, Petr Chlapek, Jaroslav Sterba, Des R Richardson, Renata Veselska
Novel Thiosemicarbazones Sensitize Pediatric Solid Tumor Cell-Types to Conventional Chemotherapeutics through Multiple Molecular Mechanisms. Cancers 12 (12) (2020)